← Markets

Kimberly-Clark Corporation

KMB · NASDAQ

Market closed$108.35$-0.640000 (-0.59%)After hours $108.34 · -0.01%

Key statistics

Previous close$108.99
Open$110.04
Day high$111.06
Day low$107.74
52-week high$137.46
52-week low$92.42
Market cap35.97B
Volume3.44M
Average volume4.67M
P/E ratio14.31
Forward P/E11.30
EPS7.57
Dividend yield+4.69%

Market context

Why it moved

KMB shares dipped modestly as the stock pulled back from its session highs despite Kimberly-Clark's better-than-expected quarterly results, with analysts maintaining a cautious "Hold" consensus and a broader market selloff — led by a chip stock decline — weighing on equities overall.

MarketbeatFintechbiznewsMarketbeatMarketbeatMarkets

What is happening

Recent company-specific developments and publisher coverage.

July 18, 2026Kimberly-Clark closed modestly lower as broader market weakness weighed on consumer staples, though the sector held up better than the broader market amid heightened risk-off sentiment driven by U.S.-Iran tensions and AI-related concerns. The stock has been buoyed recently by a wave of institutional accumulation — with firms like Point72, Wealthfront, Bleakley Financial, and Fifth Third Bancorp all raising stakes — and UBS lifted its price target to $115 on the day. Analysts maintain a consensus Hold with an average target of ~$116.79, supported by a solid Q1 beat ($1.97 EPS vs. $1.93 est.) and a resilient 4.7% dividend yield.

-0.5872

July 17, 2026Kimberly-Clark rose solidly, outperforming the broader market as consumer staples staged their strongest session since April 2025, with the XLP sector ETF surging roughly 2.6% while the S&P 500 slipped 0.4% amid AI and tech stock weakness. The defensive rotation benefited KMB, which also received a fresh analyst catalyst as UBS raised its price target from $106 to $115 while maintaining a Neutral rating, reflecting improved confidence in the company's innovation-driven growth strategy and solid Q1 results that beat on both EPS ($1.97 vs. $1.93 est.) and revenue ($4.16B vs. $4.09B est.). Adding to the investment case, a pending merger with Kenvue in the second half of 2026 and KMB's 54-year dividend growth streak continue to attract income-oriented investors.

2.3092

July 16, 2026Kimberly-Clark closed essentially flat, edging down slightly as consumer defensive names saw muted activity while broader markets digested a softer-than-expected June CPI report. Investor attention has been drawn to the company's innovation strategy and a recent peer comparison piece against Church & Dwight, while Wells Fargo raised its price target to $110 (equal weight) last week and Piper Sandler carries an overweight rating with a $121 target. The stock has rebounded sharply from its 52-week low of $92.42, with Q1 earnings topping estimates at $1.97 EPS on $4.16B in revenue (+2.7% YoY), and a ~4.8% dividend yield providing income support. In after-hours trading, shares are bouncing back up ~0.91%.

-0.2715

July 15, 2026Kimberly-Clark fell sharply, underperforming the broader S&P 500 which closed modestly higher after a cooler-than-expected June CPI report. The decline came as the consumer defensive sector (XLP) also sold off, with investors rotating toward growth and tech names on the inflation relief news rather than defensives. Analyst sentiment remains cautious with a consensus Hold rating and an average price target of $116.14, while Wells Fargo recently upgraded its target to $110 and Piper Sandler set an overweight with a $121 target. The stock has slipped roughly 9% over the past year and now trades below its 52-week high of $137.46, though Q1 earnings beat estimates and a 4.6% dividend yield continues to attract income-oriented investors.

-3.0496

July 14, 2026Kimberly-Clark shares declined nearly 2% on above-average volume as a broad market selloff driven by renewed U.S.-Iran military tensions and surging oil prices weighed on equities, with the consumer staples sector (XLP) also retreating. Adding a specific overhang, a federal appeals court revived lawsuits linking Kenvue's Tylenol to autism, a notable risk given the pending ~$50B Kimberly-Clark acquisition of Kenvue. Analyst sentiment remains cautious at a consensus Hold with a $116.14 average price target, though Wells Fargo recently raised its target to $110 and Piper Sandler lifted its target to $121 with an Overweight rating, while the company's Q1 beat and 4.6% dividend yield continue to underpin investor interest.

-1.9838

July 11, 2026Kimberly-Clark rose, outperforming the broader consumer staples sector (XLP) as investors rotated into defensive dividend plays amid ongoing U.S.-Iran tensions and ahead of Q2 earnings season. The maker of Huggies and Kleenex benefited from a broader flight-to-safety narrative, with its ~4.7% dividend yield and Q1 earnings beat (EPS $1.97 vs. $1.93 est., revenue $4.16B vs. $4.09B expected) drawing renewed institutional interest — multiple firms increased their stakes in Q1 — while Piper Sandler's recent upgrade to Overweight with a $121 target adds to cautious optimism around the stock.

2.256

July 10, 2026Kimberly-Clark edged lower, retreating with the broader consumer staples sector as renewed U.S.-Iran hostilities stoked inflation fears and weighed on defensive names. The XLP sector ETF also pulled back on the day. Investors are keeping an eye on the company's Arbex joint venture with Suzano — a $3.4B partnership that closed July 1 and divests its International Family Care & Professional division — as a key strategic catalyst, even as Wells Fargo recently raised its price target to $110 while maintaining an equal weight rating. With Q2 results scheduled for August 4 and a Hold consensus among analysts (avg. target ~$115), the upcoming earnings report will be a key test for whether the recent rally can be sustained.

-0.9461

July 9, 2026Kimberly-Clark fell sharply as a broad macro-driven risk-off session reversed recent defensive-sector tailwinds, with President Trump declaring the U.S.-Iran ceasefire 'over,' sending oil surging 4-5% and lifting inflation fears that pressured consumer staples names despite their traditionally defensive appeal. The selloff was notable given KMB had recently been trading near its consensus analyst price target of $115.43 — supported by a Q1 earnings beat, 2.7% revenue growth, and a 4.5% dividend yield — and multiple institutional investors had been adding to positions. Wells Fargo maintained an Equal-Weight rating with a $110 price target, now roughly in line with current levels.

-3.277

Simply Wall Street · July 18, 2026Is Kimberly Clark (KMB) Below Fair Value Following Arbex Going Independent?Simply Wall Street · July 16, 2026Will Rising Institutional Buying of KMB’s Defensive Hygiene Franchise Change Kimberly-Clark's (KMB) NarrativeSupply Chain Dive · June 15, 2026Kimberly-Clark credits supply chain for productivity gainsSeeking Alpha · June 3, 2026Kimberly-Clark: 5% Yield Looks Attractive, But Still Looking For Growth To Show Up (KMB)TIKR.com · May 18, 2026Kimberly-Clark CEO Just Answered the Two Questions Every KMB Investor Is AskingPR Newswire · April 28, 2026Kimberly-Clark Announces First Quarter 2026 Results, Reaffirms 2026 OutlookPR Newswire · October 30, 2025Kimberly-Clark Announces Third Quarter 2025 Results, Updates 2025 OutlookKenvue Investor Relations · March 11, 2025Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader
Benzinga · July 16, 2026UBS Maintains Neutral on Kimberly-Clark, Raises Price Target to $115
Mt Newswire · July 16, 2026UBS Adjusts Price Target on Kimberly-Clark to $115 From $106, Maintains Neutral Rating
Benzinga · July 8, 2026Wells Fargo Maintains Equal-Weight on Kimberly-Clark, Raises Price Target to $110
Mt Newswire · June 23, 2026Barclays Adjusts Price Target on Kimberly-Clark to $101 From $99, Maintains Equalweight Rating
Benzinga · June 17, 2026Piper Sandler Maintains Overweight on Kimberly-Clark, Raises Price Target to $121
Mt Newswire · June 17, 2026Piper Sandler Adjusts Price Target on Kimberly-Clark to $121 From $115, Maintains Overweight Rating
Mt Newswire · May 14, 2026Kimberly-Clark Keeps Quarterly Dividend at $1.28 a Share, Payable July 2 to Holders of Record June 5
Mt Newswire · May 12, 2026Suzano's Proposed Acquisition of Kimberly-Clark IFP Gets European Commission Approval

Peers

S&P 500SPX · $7,457.69-1.01%The Procter & Gamble CompanyPG · $149.96-1.02%Unilever PLCUL · $62.39-0.51%Colgate-Palmolive CompanyCL · $92.98-1.16%Kenvue Inc.KVUE · $18.98-0.21%The Clorox CompanyCLX · $96.32-2.42%Church & Dwight Co., Inc.CHD · $98.07-1.06%Edgewell Personal Care CompanyEPC · $29.66+1.64%Reckitt Benckiser Group plcRKT.L · 5,086.00-0.12%Essity AB (publ)ESSITY-A.ST · 282.00+3.49%Henkel AG & Co. KGaAHENKY · $20.22-1.00%Newell Brands Inc.NWL · $5.23-3.68%